RUNX1 and leukemia: Collectively, our data highlight MGA as an important regulator of pathways critical for leukemia development, such as MYC activation, cell cycle, and oxidative phosphorylation, and that loss of function mutations identified in patients can functionally cooperate with the RUNX1::RUNX1T1 oncoprotein [21, 38–41].